Abstract
Signal transduction systems are known to widely regulate complex biological events such as cell proliferation and differentiation. Although numerous biological analyses have revealed many of the key molecules and events involved in cell signaling, an integrative view of this complicated system cannot provide a fundamental theory on the regulation of the entire network without analyzing the dynamic behavior of these molecules and events at the system level. Recent technological advances in mass spectrometry-based proteomics and bioinformatics have enabled us to obtain a networkwide description of signaling dynamics through the large-scale identification and quantification of phosphorylated molecules. Accordingly, computational modeling on the basis of dynamic proteomics data has also been applied to the network analysis of representative signaling systems such as the epidermal growth factor receptor pathway. This review focuses on the current status of quantitative proteomics technology for temporal studies of signal transduction and on the application of comprehensive signaling dynamics data to mathematical analyses of regulatory networks. The perspective on proteomics data-driven systems biology is also discussed.
Keywords: Signal transduction, quantitative proteomics, systems biology, LC-MS/MS, computational modeling
Current Bioinformatics
Title: Comprehensive Description of Signal Transduction Networks by Quantitative Proteomics and Systems Biology
Volume: 4 Issue: 2
Author(s): Masaaki Oyama
Affiliation:
Keywords: Signal transduction, quantitative proteomics, systems biology, LC-MS/MS, computational modeling
Abstract: Signal transduction systems are known to widely regulate complex biological events such as cell proliferation and differentiation. Although numerous biological analyses have revealed many of the key molecules and events involved in cell signaling, an integrative view of this complicated system cannot provide a fundamental theory on the regulation of the entire network without analyzing the dynamic behavior of these molecules and events at the system level. Recent technological advances in mass spectrometry-based proteomics and bioinformatics have enabled us to obtain a networkwide description of signaling dynamics through the large-scale identification and quantification of phosphorylated molecules. Accordingly, computational modeling on the basis of dynamic proteomics data has also been applied to the network analysis of representative signaling systems such as the epidermal growth factor receptor pathway. This review focuses on the current status of quantitative proteomics technology for temporal studies of signal transduction and on the application of comprehensive signaling dynamics data to mathematical analyses of regulatory networks. The perspective on proteomics data-driven systems biology is also discussed.
Export Options
About this article
Cite this article as:
Oyama Masaaki, Comprehensive Description of Signal Transduction Networks by Quantitative Proteomics and Systems Biology, Current Bioinformatics 2009; 4 (2) . https://dx.doi.org/10.2174/157489309788184738
DOI https://dx.doi.org/10.2174/157489309788184738 |
Print ISSN 1574-8936 |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-392X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Targeting JAK/STAT Signaling Pathway in Inflammatory Diseases
Current Signal Transduction Therapy A Systematic Review of Genes Involved in the Inverse Resistance Relationship Between Cisplatin and Paclitaxel Chemotherapy: Role of BRCA1
Current Cancer Drug Targets Corticotropin-Releasing Factor Receptor Antagonists in Affective Disorders and Drug Dependence - An Update
CNS & Neurological Disorders - Drug Targets Applications of Mesoporous Materials as Excipients for Innovative Drug Delivery and Formulation
Current Pharmaceutical Design Advances in Oncolytic Virus Therapy for Glioma
Recent Patents on CNS Drug Discovery (Discontinued) MicroRNAs-based Therapy: A Novel and Promising Strategy for Cancer Treatment
MicroRNA Agave (Agave spp.) and its Traditional Products as a Source of Bioactive Compounds
Current Bioactive Compounds Heme Oxygenase-1 and Breast Cancer Resistance Protein Protect Against Hemeinduced Toxicity
Current Pharmaceutical Design A Comprehensive Review on Ethnomedicinal, Pharmacological and Phytochemical Basis of Anticancer Medicinal Plants of Pakistan
Current Cancer Drug Targets Editorial (Thematic Issue: <i>In Silico</i> Drug Design and Medicinal Chemistry)
Current Topics in Medicinal Chemistry Novel 1,2,3-Triazole-functionalized pyrido[3',2':4,5]furo[3,2-d]pyrimidin- 4(3H)-one Derivatives: Synthesis, Anticancer Activity, CoMFA and CoMSIA Studies
Letters in Organic Chemistry The Means to an End of Tumor Cell Resistance to Chemotherapeutic Drugs Targeting Thymidylate Synthase: Shoot the Messenger
Current Drug Targets JAK Inhibitors: Pharmacology and Clinical Activity in Chronic Myeloprolipherative Neoplasms
Current Medicinal Chemistry Topomer CoMFA 3D-QSAR and Docking Studies of Pyrimidine Inhibitors of Pneumocystis Carinii Dihydrofolate Reductase
Letters in Drug Design & Discovery Patent Selections:
Recent Patents on Anti-Cancer Drug Discovery Antiviral Immunotherapy for Mosquito-Borne Flaviviruses: A Review of Current Status
Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) Episensitization: Therapeutic Tumor Resensitization by Epigenetic Agents: A Review and Reassessment
Anti-Cancer Agents in Medicinal Chemistry Small Molecule Inhibitors Targeting Key Proteins in the DNA Damage Response for Cancer Therapy
Current Medicinal Chemistry Role of T Lymphocytes in the Development of Rheumatoid Arthritis. Implications for Treatment
Current Pharmaceutical Design Computer-Aided Drug Design Applied to Secondary Metabolites as Anticancer Agents
Current Topics in Medicinal Chemistry